Suchergebnisse - "de Azambuja, E"

PubPharm (6)

1

Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases : a systematic review and meta-analysis

enthalten in: ESMO open | 2022

von Nader-Marta, G. | Martins-Branco, D. | Agostinetto, E. | +7

2

Are we assuming too much with our statistical assumptions? Lessons learned from the ALTTO trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Holmes, E. | Bradbury, I. | Williams, L. | +9

CommentIn: Ann Oncol. 2019 Sep 1;30(9):1415-1416. - PMID 31271411

3

The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer : Results from Neo-ALTTO

enthalten in: European journal of cancer (Oxford, England : 1990) | 2018

von Di Cosimo, S. | Campbell, C. | Azim, H. | +18

4

Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination : A meta-analysis of randomized controlled trials

enthalten in: Cancer treatment reviews | 2017

von Solinas, C. | Ceppi, M. | Lambertini, M. | +9

5

Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer : the LAPTEM trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von de Azambuja, E. | Zardavas, D. | Lemort, M. | +13

6

Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer : results from the NeoALTTO phase III trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Criscitiello, C. | Azim, H. | Agbor-tarh, D. | +7

CommentIn: Ann Oncol. 2014 Apr;25(4):909-10. - PMID 24608195

1
[1]